The number of deaths due COVID-19 amounts to 3 million worldwide, according to data from Johns Hopkins University. More than 566,000 of these deaths have been in the United States, where coronavirus cases are now on the rise, despite efforts to vaccinate humans.
About 40% of Americans have received at least one dose of COVID and almost a quarter of them have been fully vaccinated.
But as Tom Hanson told CBS this morning: Saturday, new variants of the virus are fueling the latest jump in cases.
“The good news is that the spread of vaccines is growing at a great pace,”
Ho is looking at another variant identified in the laboratory of Columbia University in New York.
“This is worrying because it is spreading at a speed that is on par with the British version, and we know that the British version is more transmissible and more deadly,” he said.
More deaths have been reported in the United States than in any other country. Globally, the number of deaths since the outbreak in Wuhan, China, more than a year ago, is more than the population of Chicago and equivalent to Dallas and Philadelphia combined. It is approximately equal to Kiev, the population of Ukraine, and the capital Lisbon, the Associated Press reported.
Video: UPMC study: Not all types of breast cancer should be treated (CBS Pittsburgh)
Click to expand
Success in controlling the virus varies considerably from country to country, and places such as India and Brazil have seen the crisis worsen.
In the United States, hunting for variants caused by mutations in the coronavirus is from coast to coast.
“Obviously we are in a danger zone,” said Washington Gov. Jay Insley.
Vaccine manufacturers are preparing for booster shots to combat the options – at least those that are known.
“Clinical trials are already underway that are looking at a boost to the original wow-type vaccine, as well as a boost with a specific variant,” said Dr. Anthony Foci.
The Biden administration is behind the pressure, announcing on Friday that $ 1.7 billion will be spent on finding options.
At the same time,The Johnson and Johnson vaccine, available only from March, remains on standby until several cases of blood clots are investigated to see if this vaccine has caused complications.
The CDC Advisory Committee is scheduled for next week to report on continued use.